Tuesday, November 10, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Efficacy, Safety and Cardiovascular Protection of Mazdutide in Type 1 Diabetes

NCT07924553 · NA · NOT YET RECRUITING · Sponsor: Peking University People's Hospital · Conditions: Type 1

PR
By Priya Raman · Science Reporter
Nov 9 07:00 ETSource: ClinicalTrials.gov

From the source

Efficacy, Safety and Cardiovascular Protection of Mazdutide in Type 1 Diabetes

NCT07924553 · NA · NOT YET RECRUITING · Sponsor: Peking University People's Hospital · Conditions: Type 1 Diabetes.

Read at clinicaltrials.gov
PeptiPrescribed peptides from $99/moSee all →